Reference : Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combinatio...
Scientific congresses and symposiums : Poster
Human health sciences : Cardiovascular & respiratory systems
Human health sciences : Oncology
http://hdl.handle.net/2268/83004
Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED SCLC).
English
Bosquee, Léon mailto [Université de Liège - ULg > > Pneumologie-Allergologie >]
2010
No
International
2010 ASCO - Annual Meeting
du02 juin 2010 au 10 juin 2010
Chicago
Etats-Unis
http://hdl.handle.net/2268/83004

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (.pdfPublisher postprint1.13 MBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.